The Corning Center for Clinical Research
The Corning Center for Clinical Research is an affiliate of Smith Allergy & Asthma Specialists of Central NY. The Center was founded by Dr. Christopher Smith to assist with the evaluation of new investigational medications, treatments and protocols for pulmonary diseases and other medical conditions.
Currently, we are looking for volunteers for the following studies:
Study 1 Atopic Dermatitis/Eczema
For patients 12 years of age or older
Duration: 12 visits over the course of 6 months
Compensation: $50 per visit
Study 2 Atopic Dermatitis/Eczema
For patients 12 years of age or older
Duration: 4 visits over the course of 5 weeks
Compensation: $50 per visit
Children’s Asthma Study
For patients 5 to 11 years of age
Duration: 8 visits over the course of approximately 29 weeks
Compensation: $150 per visit
Clinical trials look at new ways to prevent, detect and treat disease. Treatments might be new drugs or new combination of drugs or new ways to use existing treatments.
People with an illness or disease participate to help others, but also to possibly receive the newest treatment and have the additional care and attention from clinical trial staff.
Who participates in clinical trials and do I qualify?
The Corning Center for Clinical Research recruits patient volunteers who have a known allergy, asthma or pulmonary health problem, enabling us to better understand the effectiveness of a particular treatment. All clinical trials have guidelines about who can participate, factors such as age, gender, type and stage of disease, previous treatment history and other medical conditions may apply. A summary of inclusion/exclusion criteria is listed for each study (see tabs above for list of studies), and detailed information is available at no charge by contacting Tracey Loid, Study Coordinator (connection to CCCR staff page) Tracey@SmithAllergy.com or call 607.684.6115.
Is a Clinical Trial safe for me?
At the Corning Center for Clinical Research, we focus on testing new treatments, new drugs and new combinations of drugs, at the Phase III trial level, where the experimental drug or treatment is administered to a large group of people (1,000–3,000 people) to confirm its effectiveness, monitor side effects, compare it with standard or equivalent treatments, and collect data that will allow the experimental drug or treatment to be used safely.
We follow FDA approved protocols that are carefully designed to safeguard your health. All clinical studies are led by our principal investigator, Dr. Christopher Smith and approved by Central Institutional Review Boards to ensure that the risks are minimal and are worth any potential benefits. Institutional Review Boards are comprised of physicians, statisticians and members of the medical community whose purpose is to ensure that clinical trials are performed ethically and that your rights as a participant are protected.
Informed consent keeps you in the know.
We provide you with the key facts about a clinical trial before you decide to participate, and on an ongoing basis throughout the study. You can rely on the Corning Center for Clinical Research team to thoroughly explain study details so you have all the information you need to make an informed decision to participate. You will receive an informed consent document detailing all aspects of the study— its purpose, duration, required procedures, and who to contact for further information. You are free to withdraw from the study or to refuse particular treatments or tests at any time, understanding, however, that this will make you ineligible to continue the study.
What questions should I ask if offered a clinical trial?
If you think you might want to participate in a clinical trial, feel free to ask any questions. The following thought starters may give you some ideas as you formulate your own questions.
What is the purpose of the study?
How long will the study last?
What will my responsibilities be if I participate?
Participation and care
What kinds of therapies, procedures and /or tests will I have during the trial?
Will I be able to take my regular medications while in the clinical trial?
Where will I have my medical care?
Cost & Compensation
Will I have to pay for any part of the trial such as tests or the study drug?
What is my health insurance likely to cover?
Will I be compensated for my time and travel costs?
IN THE END WHAT HAPPENS?
Once your clinical trial is finished, researchers will thoroughly analyze data collected during the study, including whether or not further testing is warranted. Once a clinical trial proves a new approach to be safe and effective, it may become the medical standard. You are welcome to contact Corning Center for Clinical Research to find out if study results have been or will be published.
We want to talk to you. Please contact:
Tracey Loid, Study Coordinator – Tracey@SmithAllergy.com 607.684.6115
Meet the staff at Corning Center for Clinical Research | Back to TOP
Dr. Smith is a nationally recognized author and researcher who trained with some of the world’s most prominent allergy and immunology experts at the prestigious Children’s Hospital of Philadelphia. While there, he conducted the hospital’s largest pediatric asthma research study. He is the author of five chapters on allergic and immunologic diseases in “The 5-Minute Pediatric Consult,” the widely used clinical resource for pediatricians, published in 1998 and updated by Dr. Smith in 2002, as well as several medical articles on asthma and allergy topics.
To date, he has conducted over 100 clinical trials in allergies, asthma, sinusitis, COPD, eczema, and new vaccine development, and has helped bring several new drug therapies to market. Dr. Smith’s strong interest in new drug therapies led him to establish the Corning Center for Clinical Research. Only a select few allergists across the country have his level of experience, and it enables him to provide individuals with research options. This is an option for those who have tried everything, and are looking for research options.
Ms. Loid has several years of experience working in clinical trials and medical research. She trained at Arnot Ogden Memorial Hospital School of Nursing and completed her Bachelor of Science Degree in Nursing at Keuka College. She completed her Master of Science Degree in Clinical Research Management through Arizona State University.
Tracey has extensive experience working with pediatric and adult patients in hospital settings as well as caring for patients in medical offices. She is comfortable providing information to participants in terms that are easy to understand, as well as accurately recording and reporting on complex clinical studies.
Lisa earned her Master’s degree in nursing from the prestigious University of Pennsylvania School of Nursing. She studied research principals with some of the national thought leaders in nursing research. Lisa has joined our research team, and serves as a sub-investigator on many of our ongoing clinical trials.